Accretion Pharmaceuticals Ltd

NSE: ACCPL · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹185.30
Market cap: ₹206.0 Cr
Revenue (annual): ₹89.63 Cr
Net profit (annual): ₹9.67 Cr
P/E (TTM): 21.3×Sector 47.4×
Promoter holding: 73.52%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Annual General Meeting 3 Financial Results 2 Results Correction 1 Management Change 1 Earnings Call 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Jul 2026 15:47 IST NSE

Management Change

Accretion Pharmaceuticals Management Change

Accretion Pharmaceuticals' HR Manager, Ms. Bandana Kumari, resigned effective 2nd July 2026. The resignation is for personal reasons, with no material issues reported.

Read the filing ↗